Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...

Related Keywords

Boston ,Massachusetts ,United States ,Cayman Islands ,American ,Adam Bero ,Wilmer Cutler Pickering Hale ,Board The Special Committee ,Season Pioneer Investments ,Company Adss ,Nasdaq ,Walkers ,American Depositary Share Of The Company ,Talent Investments ,Morningside Venturei Investments ,Houlihan Lokey Capital Inc ,Investor Relations For The Company ,Company Adss On ,Stealth Biotherapeutics Inc ,Stealth Parent ,Stealth Merger Sub ,Morningside Venturei Investments Ltd ,Exchange Commission ,Company Board ,Stealth Biotherapeutics Corp Nasdaq ,Goodwin Procter ,Companies Act Of The Cayman ,Stealth Parent Limited ,Stealth Merger Sub Limited ,Morningside Venture ,Capital Advisors ,Merger Agreement ,Merger Sub ,Effective Time ,Share Merger ,American Depositary Share ,Companies Act ,Special Committee ,Investments Limited ,Season Pioneer Investments Limited ,Equal Talent Investments Limited ,Lokey Capital ,Information About ,Private Securities Litigation Reform Act ,Annual Report ,